Company
Headquarters: Cologne, Germany
Employees: 388
CEO: Dr. Frank Nicolas Antwerpes
€64.0 Million
EUR as of July 1, 2025
US$75.6 Million
| Company | Market Cap (USD) |
|---|---|
| Veeva Systems Inc. | $46.46 B |
| GE HealthCare | $34.85 B |
| Change Healthcare Inc. | $9.03 B |
| M3, Inc. | $8.98 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
DocCheck AG offers marketing, customer relationship management, and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, and online and e-commerce services for healthcare market players. It also develops and implements communication strategies for new and traditional media on healthcare and business-to-business sectors; and promotes healthcare startups through seed funding. DocCheck AG is based in Cologne, Germany.
DocCheck AG has the following listings and related stock indices.
Stock: FSX: AJ91 wb_incandescent
Stock: XETR: AJ91 wb_incandescent